Literature DB >> 3652099

Dissociation between early recovery of regional function and purine nucleotide content in postischaemic myocardium in the conscious dog.

D D Glower1, J A Spratt, J R Newton, J A Wolfe, J S Rankin, J L Swain.   

Abstract

Since abnormalities in regional myocardial function and nucleotide metabolism persist for a prolonged period after a brief coronary occlusion the temporal relation between the resolution of myocardial dysfunction and repletion of nucleotide pools in postischaemic myocardium was studied in conscious mildly sedated animals. In a second experiment 5-amino-4-imidazolecarboxamide riboside (AICAriboside) was infused in an attempt to influence myocardial function by altering the rate of adenine nucleotide synthesis. Conscious dogs mildly sedated with morphine underwent coronary occlusion for 15 min followed by reperfusion for 30 min or 12 h, at which time a myocardial sample was obtained for nucleotide analysis. Segment shortening averaged 62% of control values at 15 min of reperfusion and increased to 81% of control by 12 h of reperfusion (p less than 0.05). Adenine nucleotide content was 75(5)% of control after 30 min of reperfusion and did not change significantly over the next 12 h of reperfusion. Thus the early return of systolic function was not accompanied by a detectable increase in total adenine nucleotide content. In the second experiment a pronounced stimulation of the proximal purine nucleotide synthetic pathway occurred as evidenced by a 13-fold to 25-fold increase in inosine monophosphate content. One branch of the distal purine pathway was also stimulated as evidenced by complete repletion of guanine nucleotide pools, but the product of the other branch (adenine nucleotides) did not increase significantly. These results indicate a selective limitation of the distal adenine nucleotide synthetic pathway in postischaemic myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652099     DOI: 10.1093/cvr/21.5.328

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Role of acadesine in clinical myocardial protection.

Authors:  A M Alkhulaifi; W B Pugsley
Journal:  Br Heart J       Date:  1995-04

Review 2.  Alterations in fatty acid oxidation in ischemic and reperfused myocardium.

Authors:  X Q Huang; A J Liedtke
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

3.  Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.

Authors:  A S Abd-Elfattah; M E Jessen; J Lekven; A S Wechsler
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

Review 4.  Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.

Authors:  Andrew M Walters; George A Porter; Paul S Brookes
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

5.  Role of aspirin in modulating myocardial ischemic reperfusion injury.

Authors:  S D Seth; M Maulik; S C Manchanda; S K Maulik
Journal:  Agents Actions       Date:  1994-05

Review 6.  Novel mechanisms mediating stunned myocardium.

Authors:  Song-Jung Kim; Christophe Depre; Stephen F Vatner
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

7.  Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina.

Authors:  D R Holdright; J L Sparrow; C L Wright; J Steiner; K M Fox
Journal:  Cardiovasc Drugs Ther       Date:  1994-04       Impact factor: 3.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.